aDepartment of infectious disease, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China
bDivision of Gastroenterology and Hepatology, Royal Victoria Hospital, McGill University Health Centre, Montreal, Québec, Canada
G.S. is supported by research salary from the Department of Medicine of McGill University.
G.S. has acted as speaker for Merck, Gilead, Abbvie, ViiV, served as an advisory board member for Merck and Novartis, and has received research funding from Merck and Echosens. C.J. has nothing to disclose. The study was not funded.